ReviewInternational journal of nanomedicine2026
Advances in the Rational Design, Mechanisms, and Applications of Lanthanide Nanoparticles for the Regulation of Reactive Oxygen Species.
Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lanthanide nanoparticles provide an ideal platform for the precise regulation of reactive oxygen species (ROS) due to their reversible redox properties, photomagnetic characteristics, and functionalizable surfaces. This review summarizes recent advances in the mechanistic understanding, biomedical applications, and material design strategies of lanthanide nanoparticles for ROS modulation. Mechanistically, lanthanide nanoparticles generate ROS through photoexcited electron transfer, Fenton-like reactions, and ligand-mediated redox cycling, while also effectively scavenging ROS via reversible valence switching and metal-ligand synergistic effects. At the application level, these nanoparticles leverage their combined antioxidant and anti-inflammatory properties to provide protection against oxidative stress-related diseases, while enabling targeted tumor elimination through chemodynamic therapy, photodynamic therapy, sonodynamic therapy, radiosensitization, and multimodal imaging. Recent material design has encompassed upconversion architectures, multi-metal composite systems, single-atom catalysts, biodegradable systems, and artificial intelligence-assisted rational design. Despite remaining challenges in understanding metabolic pathways and achieving targeting precision, the integration of lanthanide nanomaterials with emerging therapeutic modalities and intelligent design strategies holds promise for innovative approaches to the diagnosis and treatment of ROS-associated diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.